Blinatumomab 作为异基因造血细胞移植后 B 系急性淋巴细胞白血病 / 淋巴瘤维持治疗的疗效。
Mesh : Humans Antibodies, Bispecific / therapeutic use Hematopoietic Stem Cell Transplantation Female Male Adult Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / therapy drug therapy Middle Aged Transplantation, Homologous Young Adult Maintenance Chemotherapy Adolescent Antineoplastic Agents / therapeutic use Treatment Outcome Aged
来 源:
DOI:10.1038/s41408-024-01092-w
PDF(Pubmed)